E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/1/2010 in the Prospect News PIPE Daily.

New Issue: Lipoxen orchestrates £1.23 million private placement of ordinary stock

By Devika Patel

Knoxville, Tenn., April 1 - Lipoxen plc said it will raise £1.23 million in a private placement of shares.

The company will sell 17,516,546 ordinary shares at 7p each.

Proceeds will be used to strengthen the company's balance sheet.

London-based Lipoxen develops vaccines and cancer drugs.

Issuer:Lipoxen plc
Issue:Ordinary shares
Amount:£1,226,158
Shares:17,516,546
Price:7p
Warrants:No
Pricing date:April 1
Stock symbol:London: LPX
Stock price:7.33p at close April 1
Market capitalization:£11 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.